This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In light of the limited availability of donor organs, particularly in Europe, the number of children requiring ventricular assist device support is rising at an unavoidable rate.MethodsWe performed a retrospective cohort study of patients who underwent a single and primary pediatricheart transplantation.
Food and Drug Adminstration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly.
This year saw exciting developments in the treatment of pediatric and congenital heartdisease. Transcatheter pulmonary valve replacement (TPVR) continued to dominate the field of interventional cardiology.
Journal of the American Heart Association, Ahead of Print. Survivorship from congenital heartdisease has improved rapidly secondary to advances in surgical and medical management. This is an updated report of the American Heart Association's previous publications on exercise in children.
Patent ductus arteriosus (PDA) is one of the most common forms of congenital heartdisease (CHD). In this report, we report a rare pediatric PDA case, complicated with PAA due to IE. Infectious endocarditis (IE) is a rare but serious complication of PDA.
Zeke and Zane were both diagnosed with hypoplastic left heart syndrome (HLHS) before birth. As far as congenital heartdiseases go, HLHS falls on the rarer end of the spectrum. The Heart Institute collaborates with the CFCC through the Fetal Cardiology Program.
A prototype of an expanding artificial heart valve could make a big dent in the number of surgeries that many kids born with congenital heartdisease need.
Recent evidence shows minimal risk of MRI in pediatric and congenital heartdisease (CHD) patients with cardiac implantable electronic devices (CIEDs), even with MRI non-conditional devices or epicardial and/or abandoned leads.
A previously published algorithm calculates recommended Full-Time Equivalent (FTE) needs for Cardiac Implantable Device (CIED) clinics, but does not account for pediatric patients (pts) and adults with congenital heartdisease (ACHD).
Use of flecainide is well-described for focal atrial tachycardia (FAT) in adult patients without structural heartdisease. However, its application in pediatric patients with congenital heartdisease (CHD) and FAT remains limited.
As pediatric cardiologists, we frequently confront emergencies necessitating rapid decision-making, while contending with the pressures of stress, fatigue, an earnest interest in “doing the right thing” and the impact of parental involvement.
6, 2025 Medtronic plc hasannounced it received CE ( Conformit Europenne ) Mark for the Harmony Transcatheter Pulmonary Valve (TPV) System, a minimally invasive alternative to open-heart surgery for congenital heartdisease patients with native or surgically repaired right ventricular outflow tract (RVOT). Eur J Heart Fail.
-based Children's National Hospital has partnered with medical device company Compremium AG to help develop new technologies designed for pediatric patients. The partnership will first focus on noninvasive monitoring of central venous pressure for congenital heartdisease patients.
Aortic dissection in pediatrics is an extremely rare condition, which is generally related to predisposing factors such as connective tissue disorders, congenital heartdisease and systemic arterial hypertensi.
They range from structural abnormalities, such as openings between the hearts chambers, to severe malformations, such as the absence of heart chambers or valves. about 12 infants in 1,000 births have a congenital heart defect, according to the Associations 2025 HeartDisease and Stroke Statistics. In the U.S.,
The American Heart Association and the American Academy of Pediatrics update recommendations for untrained lay rescuers and trained rescuers resuscitating adults and children who have drowned.
5 MHz Higher frequency like 7-10 MHz can be used in pediatric imaging and in transesophageal echocardiography. Same applies to transesophageal echocardiography where heart is just in front of the esophagus. Reference: Braunwald’s HeartDisease, 12 th Edition, Page 197 7-10 MHz Correct answer: B.
The guideline reiterates the importance of collaborative decision-making with patients who have HCM and provides updated recommendations for the most effective treatment pathways for adult and pediatric patients.
Guidelines addressing magnetic resonance imaging (MRI) in patients with cardiac implantable electronic devices (CIEDs) provide algorithms for imaging pediatric and congenital heartdisease (CHD) patients. Guideline acceptance varies by institution.
citizen, national, or permanent resident; meet educational and credential requirements; and either be employed or begin training as a pediatric specialist at a PSLRP-approved site serving a medically underserved area or population. This program invests in current and future pediatric cardiothoracic surgeons to meet the growing demand.
Nowhere is the need for fully absorbable metal stents greater than in patients experiencing vascular anomalies associated with congenital heartdisease (CHD). We also discuss the challenges and our center's experience associated with the use of absorbable metal stents in this pediatric population.
BackgroundExercise parameters can be altered in children with congenital heartdisease or acquired heartdisease compared with children with normal hearts. Exercise testing has proven a useful tool to predict patient outcomes and even the need for reintervention in several cardiovascular disease processes.
Aims A proportion of patients with pulmonary arterial hypertension associated with congenital heartdisease (PAH-CHD) do not fit in the current classification. The role of ASD in pediatric PH should be reconsidered. No survival difference could be demonstrated between the groups.
Addressing an Unmet Need in Pediatric Patients with HeFH Heterozygous familial hypercholesterolemia (HeFH) affects about 1 in 313 people—characterized by dangerously high low-density lipoprotein cholesterol (LDL-C) levels. Untreated, it can trigger early heartdisease.
Smartwatch-enabled detection of left ventricular systolic dysfunction (LVSD) shows promise in the general adult population; however, it has yet to be explored in the pediatric and adult congenital heartdisease (CHD) population.
Pathogeneses include connective tissue disorders, smooth muscle contraction disorders, and congenital heartdisease, including bicuspid aortic valve, among others. The American Heart Association has published guidelines for diagnosis and management of thoracic aortic disease.
History of the Congenital Heart Futures Act First passed into law in 2010, the bipartisan Congenital Heart Futures Act was groundbreaking legislation authorizing research and data collection specific to Congenital HeartDisease. Raising awareness of CHD through the lifespan.
Systemic inflammatory response syndrome (SIRS) and capillary leak syndrome (CLS) are frequent complications after pediatric cardiac surgery increasing morbidity, therefore early diagnosis and therapy is crucial. To our knowledge this is the first clinical study to assess CIRBP serum concentrations in a pediatric population.
Wearable biosensors (wearables) enable continual, noninvasive physiologic and behavioral monitoring at home for those with pediatric or congenital heartdisease. Challenges related to the use of wearables are common to every clinical setting, but specific topics for consideration in congenital heartdisease are highlighted.
ABSTRACT Introduction The aim of this study was to describe our experience and outcome of ablation therapy for arrhythmias in pediatrics at a tertiary care center. All pediatrics presenting to AUBMC between 2000 and 2020 who underwent cardiac ablation were included. Structural heartdisease was present in 6% of patients.
Abstract Introduction Supraventricular tachycardia (SVT) is a common pediatric arrhythmia. We describe the prescriptive tendencies, efficacy, and tolerability of BBs and CCBs used in the treatment of pediatric SVT. Exclusion criteria were pre-excitation, ectopic atrial tachycardia, and hemodynamically significant heartdisease.
Attendees can join with their peers and participate in sessions on structural heartdisease, congenital heartdisease, guidelines and trials, AI/Machine learning, technical aspects of cardiac CT, coronary artery disease, vascular heartdisease, debates and games and early career topics.
However, current experience using ivabradine for FAT in children is limited to small case series, often not involving congenital heartdisease (CHD) patients.(1, Ivabradine’s high selectivity and minimal side effects make it an attractive candidate for wider applications such as focal atrial tachycardia (FAT).
This can be an especially trying time in the life of an adolescent with congenital heartdisease, especially as they are undergoing the major transition of leaving the nest and going off to college, joining the workforce, or just moving far from home. He is trained in both Adult Cardiovascular Medicine and Pediatric Cardiology.
Leadless pacemakers (LP) have offered unique pacing solutions in patients to avoid the vascular and infectious issues associated with traditional endocardial pacemakers. The AveirTM (Abbott Laboratories) has a helix fixation system that distinguishes it from prior LP designs.
Device based vascular closure has shortened bedrest and post-procedure care after electrophysiology case (EPS) in adult studies. VASCADETM (Cardiva Medical) devices establish hemostasis by delivering resorbable, extravascular collagen into the tissue tract.
Cincinnati Children's and the Christ Hospital Health Network, also in Cincinnati, have partnered on a clinic to address the needs of patients with congenital heartdisease as they age out of pediatric care.
Objective To report the number of thromboembolic complications in a cohort of pediatric and young adult patients presenting with atrial fibrillation (AFib) or atrial flutter (AFl) while also assessing anticoagulation practice in a multicenter cohort of young patients with these arrhythmias.
McNamara Keynote Unlocking the Diversity Key in the Pediatric and Adult Congenital HeartDisease Workforce Saturday, April 6, Noon – 1:15 p.m. Isabel-Jones, MD , Professor Emeritus of Pediatrics, UCLA Health. From Civil Rights to Patient Equity — A Legacy of Strength” Presented by Josephine B.
Background:Asynchronous remote patient monitoring (RPM) is increasingly common in healthcare models for infants with congenital heartdisease (CHD). HCTs reported improved communication (4.5+.77) 77) and clinical decision-making with video reviews (4.47+.79). Parents' data engagement averaged 268+195.3
Journal of the American Heart Association, Ahead of Print. BackgroundThe complexity of congenital heartdisease has been primarily stratified on the basis of surgical technical difficulty, specific diagnoses, and associated outcomes. had underlying congenital heartdisease; 44.8% were outpatient; 34.5%
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
52 
Let's personalize your content